logo

For the Inventor, By the Inventor

Dollard des Ormeaux, Canada

Chun-Sing Li

This inventor holds 9 USPTO granted patents. Top assignees: Merck Frosst Canada, Inc., Merck Frosst Canada & Co.. Active years: 1995-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chun-Sing Li. Retrieved from https://idiyas.com/inventor/chun-sing-li-sv13a4fv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 88.9

Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 604(Granted Patents)


Location History:

  • Kirkland, CA (1999)
  • Dollard Des Ormeaux, CA (1995 - 2002)

Company Filing History:

goldMedal6 out of 212 
 
Merck Frosst Canada, Inc.
 patents
silverMedal3 out of 80 
 
Merck Frosst Canada & Co.
 patents

Years Active: 1995-2002

Loading Chart...
9 patents (USPTO):Explore Patents
1. 6465509 - Pyrones as inhibitors of cyclooxygenase-2 (2002-10-15),
2. 6211210 - Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use (2001-04-03),
3. 6169188 - (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors (2001-01-02),
4. 6020343 - (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors (2000-02-01),
5. 5981576 - (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors (1999-11-09),
6. 5968958 - 5-Methanesulfonamido-3H-isobenzofuran-1-ones as inhibitors of (1999-10-19),
7. 5604260 - 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 (1997-02-18),
8. 5552422 - Aryl substituted 5,5 fused aromatic nitrogen compounds as (1996-09-03),
9. 5409944 - Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase (1995-04-25),

Title: The Innovative Contributions of Chun-Sing Li

Introduction

Chun-Sing Li is a notable inventor based in Dollard des Ormeaux, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. With a total of 9 patents to his name, his work has had a meaningful impact on medical research and treatment options.

Latest Patents

Among his latest patents, Chun-Sing Li has developed innovative compounds such as "Pyrones as inhibitors of cyclooxygenase-2" and "Diphenyl-1,2,3-thiadiazol-3-oxides." These inventions encompass compounds of Formula I and include methods for treating COX-2 mediated diseases. The treatment involves administering a non-toxic therapeutically effective amount of a compound of Formula I to patients in need.

Career Highlights

Chun-Sing Li has worked with prominent companies in the pharmaceutical industry, including Merck Frosst Canada, Inc. and Merck Frosst Canada & Co. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Throughout his career, Chun-Sing Li has collaborated with esteemed colleagues such as Michel Therien and Jacques Yves Gauthier. These partnerships have fostered an environment of innovation and have led to the successful development of various pharmaceutical compounds.

Conclusion

Chun-Sing Li's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence medical research and treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…